Historical Stock Price
ETFs Holding AMGN »    AMGN Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
04/14/2021 $249.98 $251.50 $249.00 $249.62 1.75M
04/15/2021 $251.10 $257.00 $250.50 $255.13 2.37M
04/16/2021 $256.44 $258.82 $254.67 $255.71 2.77M
04/19/2021 $252.85 $256.11 $252.64 $255.97 2.35M
04/20/2021 $254.84 $260.36 $254.84 $259.14 1.58M
Amgen is a biotechnology company that discovers, develops, manufactures and delivers human therapeutics. Co.'s products include: Enbrel® (etanercept), which is used in indications for the treatment of adult patients with moderately to severely active rheumatoid arthritis, patients with chronic moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy and patients with active psoriatic arthritis; and Prolia® (denosumab), which it is used for the treatment of postmenopausal women with osteoporosis at high risk of fracture or multiple risk factors for fracture; or in patients who have failed or are intolerant to other available osteoporosis therapy.
AMGN historical stock prices picture
Amgen (AMGN) has the following price history information. Looking back at AMGN historical stock prices for the last five trading days, on April 14, 2021, AMGN opened at $249.98, traded as high as $251.50 and as low as $249.00, and closed at $249.62. Trading volume was a total of 1.75M shares. On April 15, 2021, AMGN opened at $251.10, traded as high as $257.00 and as low as $250.50, and closed at $255.13. Trading volume was a total of 2.37M shares. On April 16, 2021, AMGN opened at $256.44, traded as high as $258.82 and as low as $254.67, and closed at $255.71. Trading volume was a total of 2.77M shares. On April 19, 2021, AMGN opened at $252.85, traded as high as $256.11 and as low as $252.64, and closed at $255.97. Trading volume was a total of 2.35M shares. On April 20, 2021, AMGN opened at $254.84, traded as high as $260.36 and as low as $254.84, and closed at $259.14. Trading volume was a total of 1.58M shares.

AMGN Historical Stock Prices By Date:

AMGN historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Amgen shares, starting with a $10,000 purchase of AMGN, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 04/21/2011
End date: 04/20/2021
Start price/share: $53.69
End price/share: $259.14
Starting shares: 186.25
Ending shares: 235.24
Dividends reinvested/share: $37.32
Total return: 509.60%
Average Annual Total Return: 19.80%
Starting investment: $10,000.00
Ending investment: $60,953.42
Years: 10.01
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/21/2011
End date: 04/20/2021
Start price/share: $53.69
End price/share: $259.14
Dividends collected/share: $37.32
Total return: 452.17%
Average Annual Total Return: 18.62%
Starting investment: $10,000.00
Ending investment: $55,205.91
Years: 10.01
Date Close
04/14/2021$249.62
04/15/2021$255.13
04/16/2021$255.71
04/19/2021$255.97
04/20/2021$259.14
AMGN is categorized under the Healthcare sector; below are some other companies in the same sector:

AMN Historical Stock Prices
AMPE Historical Stock Prices
AMPH Historical Stock Prices
AMRI Historical Stock Prices
AMRN Historical Stock Prices
AMS Historical Stock Prices
AMSG Historical Stock Prices
ANAB Historical Stock Prices
ANAC Historical Stock Prices
ANCI Historical Stock Prices

Also explore: AMGN shares outstanding history

AMGN Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.